Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

CSE:PHRM - Post Discussion

Pharmather Holdings Ltd > Train About to Leave!! Hope Your On Board!!
View:
Post by Guytorule on Nov 01, 2024 4:48pm

Train About to Leave!! Hope Your On Board!!

Day by Day, buying occuring and share price rises slowly. Market depth shows very little shares available to buy up to .39 cents. One large investors will take this to .50 cents quickly in a blink of an eye. This is in anticipation of a company response to FDA minor dificiency and the imminent FDA approval to be announced shortly thereafter. Four years in the making when they completed their initial IPO listing in late 2020 and had reached a high then of $1.27 / share in mid June of 2021. Long awaited approval of their "Ketarx" lead product to address and fill the global unmet medical need around the world for Ketamine for sedation, anesthesia, pain and mental health. Approval finally here very shortly. Low Share count of 88mm shares out, CEO/Founder owns 19% of float and been buying big last 2 years having over 15.5 millions shares in his name. No debt, $2mm cash on hand and will have a very large revenue model to address a market in this field of over $1.5 billion plus dollars. No brainer here...Risk/Reward will be massive..Good luck to all, bought a little more again today on daily lows. Remember, don't get greedy, take profits along the way...
Comment by Guytorule on Nov 01, 2024 5:14pm
No Pumping here, just the facts about this company and its future growth potential. Do your own due diligence and you will find all the facts and info you need on this opportunity with potential to gain 10X your return on your investment. Research is a must, and when you find a company/penny stock with this much potential I take the opportunity to load up and hold and wait for the outcome I seek ...more  
Comment by Itistoo on Nov 02, 2024 2:43pm
I've been in this play for a few years now and just waiting for an exit now. I have a relatively low average for my shares at .15 cents CAD. I've had opportunities to sell the pumps which I probably should have done in hindsight, but my goal was always to hold this until fruition (or failure). I've waited this long and will continue to wait as they are very close imo to inevitable FDA ...more  
Comment by Guytorule on Nov 02, 2024 4:04pm
Good for you and well said. Your in-the-money currently, and great for you, I'm in same position,  and have averaged down every opportunity.  One at there own risk level to capitalize on a profit here must set their own exit price. Not necessarily hold right up to the possible end game of a possible take-out by large Pharma, may happen, may not, but certainly it appears FDA approval ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities